Support PenkeVertex Pharmaceuticals Inc - Trending symbols
Latest News of Vertex Pharmaceuticals Inc
| Date | Title | Read |
|---|---|---|
| 2025-01-27 13:30 | Vertex to Announce Fourth Quarter and Full Year 2024 Financial Results on February 10 | Read |
| 2025-01-22 17:05 | Antibody Drug Conjugates Market Size is Expected to Reach USD 25.38 Billion by 2033, Growing at a CAGR of 8.84%: Straits Research | Read |
| 2025-01-18 12:40 | 3 Unstoppable Stocks to Buy in 2025 | Read |
Trends
| 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Income before Tax | 1,161,500 | 17,700 | 1,179,200 | -31,600 | 1,147,600 | 131,500 | 1,279,100 | -4,670,300 | -3,391,200 | |
| Net Income | 915,700 | 119,600 | 1,035,300 | -66,500 | 968,800 | 130,800 | 1,099,600 | -4,693,200 | -3,593,600 | |
| EBIT | 1,026,400 | 174,500 | 1,200,900 | -242,100 | 958,800 | 177,200 | 1,136,000 | -4,661,100 | -3,525,100 | |
| EBITDA | 1,282,600 | -39,600 | 1,243,000 | -225,200 | 1,017,800 | 171,700 | 1,189,500 | -4,660,600 | -3,471,100 | |
| Operating Income | 1,026,400 | 11,700 | 1,038,100 | -79,300 | 958,800 | 177,200 | 1,136,000 | -4,661,100 | -3,525,100 | |
| Net Income from Continuing Operations | 915,700 | 119,600 | 1,035,300 | -66,500 | 968,800 | 130,800 | 1,099,600 | -4,693,200 | -3,593,600 | |
| Accumulated Other Comprehensive Income | -13,100 | -26,700 | -39,800 | 36,800 | -3,000 | -11,300 | -14,300 | 31,600 | 17,300 | |
| Net Interest Income | -14,139 | 239 | -13,900 | 600 | -13,300 | 9,500 | -3,800 | 36,300 | 32,500 |
Comments
How you think about this?